Atlas Venture Fund XI, L.P.
CIK 1708269 · last filed 2024-11-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
IKNA price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
10TH FLOOR
CAMBRIDGE, MA 02139
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Third Harmonic Bio, Inc. (THRD) Delisted | 10%+ Owner | 9,798,075 | $5.38 | $52.71M | $0 | 1 | 2024-11-05 |
| Day One Biopharmaceuticals, Inc. (DAWN) Delisted | 10%+ Owner | 6,008,534 | $21.53 | $129.36M | $0 | 3 | 2022-12-14 |
| ImageneBio, Inc. (IKNA) Delisted | 10%+ Owner | 176,381 | $17.16 | $3.03M | $1.61M | 1 | 2021-12-14 |
| DYN | 10%+ Owner | 7,326,117 | $16.09 | $117.84M | $0 | 1 | 2021-07-15 |
| Akero Therapeutics, Inc. (AKRO) Delisted | 10%+ Owner | 2,706,412 | $54.65 | $147.91M | $0 | 1 | 2020-01-02 |
Holdings By Holder
| Symbol | Holder | Shares | Share of Total | Reported |
|---|---|---|---|---|
| IKNA | Direct | 103,495 | 58.7% | 2021-12-14 |
| Atlas Venture Opportunity Fund I, L.P. See footnote |
72,886 | 41.3% | 2021-12-14 | |
| Total | 176,381 | |||
| AKRO | AVF XI See footnote |
2,706,412 | 100.0% | 2020-01-02 |
| Total | 2,706,412 |
Recent Filings · Page 6 of 6
53 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-11-29 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Other (J) | −801,138 | $0 | EDGAR |
| 2021-07-15 | DYN | Other (J) | −814,013 | $0 | EDGAR |
| 2020-01-02 | Akero Therapeutics, Inc. (AKRO) Delisted | Other (J) | −242,883 | $0 | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).
Sales Reported Only on Form 144
63 sales · $59.16M| Sold | Symbol | Shares | Proceeds | Avg Price | Listed On |
|---|---|---|---|---|---|
| 2026-11-11 | KRRO | 22,026 | $332.1K | $15.08 | 2026-11-12 |
| 2026-11-11 | KRRO | 4,561 | $68.8K | $15.08 | 2026-11-12 |
| 2026-09-14 | KRRO | 31,887 | $450.2K | $14.12 | 2026-11-12 |
| 2026-09-14 | KRRO | 6,603 | $93.2K | $14.12 | 2026-11-12 |
| 2026-09-11 | KRRO | 8,450 | $118.2K | $13.99 | 2026-09-14 |
| 2026-09-11 | KRRO | 1,750 | $24.5K | $13.99 | 2026-09-14 |
| 2026-08-26 | KRRO | 249 | $3.5K | $13.96 | 2026-09-11 |
| 2026-08-26 | KRRO | 51 | $712 | $13.96 | 2026-09-11 |
| 2026-08-19 | KRRO | 23,584 | $330.2K | $14.00 | 2026-08-26 |
| 2026-08-19 | KRRO | 4,884 | $68.4K | $14.00 | 2026-08-26 |
| 2026-08-11 | KRRO | 1,775 | $24.8K | $13.96 | 2026-08-19 |
| 2026-08-11 | KRRO | 368 | $5.1K | $13.96 | 2026-08-19 |
| 2026-07-06 | KRRO | 817 | $11.4K | $13.96 | 2026-08-11 |
| 2026-07-06 | KRRO | 8,506 | $118.7K | $13.96 | 2026-08-11 |
| 2026-07-02 | KRRO | 85,955 | $1.21M | $14.03 | 2026-07-06 |
| 2026-07-02 | KRRO | 14,745 | $206.9K | $14.03 | 2026-07-06 |
| 2026-06-24 | KRRO | 41,345 | $603.7K | $14.60 | 2026-07-02 |
| 2026-06-24 | KRRO | 7,093 | $103.6K | $14.60 | 2026-07-02 |
| 2026-06-23 | KRRO | 101,579 | $1.45M | $14.25 | 2026-06-24 |
| 2026-06-23 | KRRO | 17,426 | $248.4K | $14.25 | 2026-06-24 |
| 2026-06-22 | KRRO | 3,382 | $47.2K | $13.95 | 2026-06-23 |
| 2026-06-22 | KRRO | 580 | $8.1K | $13.95 | 2026-06-23 |
| 2026-05-28 | KRRO | 2,441 | $34.1K | $13.95 | 2026-06-22 |
| 2026-05-28 | KRRO | 419 | $5.8K | $13.95 | 2026-06-22 |
| 2026-04-20 | DYN | 142,571 | $2.86M | $20.06 | 2026-04-21 |
| 2026-04-20 | DYN | 71,722 | $1.44M | $20.06 | 2026-04-21 |
| 2026-04-20 | DYN | 56,355 | $1.13M | $20.06 | 2026-04-21 |
| 2026-04-20 | DYN | 1,401 | $28.1K | $20.06 | 2026-04-21 |
| 2025-10-20 | SION | 46,273 | $1.49M | $32.09 | 2025-10-21 |
| 2025-10-20 | SION | 9,712 | $311.7K | $32.09 | 2025-10-21 |
| 2025-10-17 | SION | 50,520 | $1.64M | $32.36 | 2025-10-20 |
| 2025-10-17 | SION | 10,604 | $343.2K | $32.36 | 2025-10-20 |
| 2025-10-16 | SION | 139,897 | $4.53M | $32.36 | 2025-10-17 |
| 2025-10-16 | SION | 29,363 | $950.1K | $32.36 | 2025-10-17 |
| 2025-10-15 | SION | 95,758 | $2.93M | $30.60 | 2025-10-16 |
| 2025-10-15 | SION | 20,098 | $615.1K | $30.60 | 2025-10-16 |
| 2025-10-14 | SION | 501 | $15.0K | $29.95 | 2025-10-16 |
| 2025-10-14 | SION | 105 | $3.1K | $29.95 | 2025-10-16 |
| 2025-10-13 | SION | 48,130 | $1.46M | $30.38 | 2025-10-16 |
| 2025-10-13 | SION | 10,102 | $306.9K | $30.38 | 2025-10-16 |
| 2025-10-10 | SION | 16,727 | $501.5K | $29.98 | 2025-10-14 |
| 2025-10-10 | SION | 3,511 | $105.3K | $29.98 | 2025-10-14 |
| 2025-10-06 | SION | 9,753 | $292.7K | $30.01 | 2025-10-10 |
| 2025-10-06 | SION | 2,047 | $61.4K | $30.01 | 2025-10-10 |
| 2025-10-03 | SION | 31,198 | $936.0K | $30.00 | 2025-10-06 |
| 2025-10-03 | SION | 6,548 | $196.5K | $30.00 | 2025-10-06 |
| 2025-10-01 | SION | 165 | $4.9K | $29.95 | 2025-10-03 |
| 2025-10-01 | SION | 35 | $1.0K | $29.95 | 2025-10-03 |
| 2025-09-30 | SION | 10,239 | $307.8K | $30.06 | 2025-10-01 |
| 2025-09-30 | SION | 2,149 | $64.6K | $30.06 | 2025-10-01 |
| 2025-09-29 | SION | 54,637 | $1.64M | $30.09 | 2025-09-30 |
| 2025-09-29 | SION | 11,468 | $345.1K | $30.09 | 2025-09-30 |
| 2024-02-26 | DYN | 201,095 | $4.77M | $23.72 | 2024-02-27 |
| 2024-02-26 | DYN | 29,808 | $707.0K | $23.72 | 2024-02-27 |
| 2024-02-26 | DYN | 17,316 | $410.7K | $23.72 | 2024-02-27 |
| 2024-02-23 | DYN | 159,542 | $3.62M | $22.70 | 2024-02-26 |
| 2024-02-23 | DYN | 23,648 | $536.8K | $22.70 | 2024-02-26 |
| 2024-02-23 | DYN | 13,738 | $311.8K | $22.70 | 2024-02-26 |
| 2024-02-22 | DYN | 119,360 | $2.70M | $22.66 | 2024-02-23 |
| 2024-02-21 | DYN | 184,501 | $4.17M | $22.58 | 2024-02-23 |
| 2024-02-20 | DYN | 169,539 | $3.85M | $22.72 | 2024-02-23 |
| 2024-02-16 | DYN | 162,707 | $3.76M | $23.14 | 2024-02-20 |
| 2024-02-15 | DYN | 177,906 | $4.25M | $23.89 | 2024-02-20 |